121 related articles for article (PubMed ID: 29719371)
41. An application of a proposed framework for formulary listing in low-income countries: the case of Côte d'Ivoire.
Diaby V; Lachaine J
Appl Health Econ Health Policy; 2011 Nov; 9(6):389-402. PubMed ID: 22017499
[TBL] [Abstract][Full Text] [Related]
42. A survey of Pharmacy and Therapeutic committees across Canada: scope and responsibilities.
Mittmann N; Knowles S
Can J Clin Pharmacol; 2009; 16(1):e171-7. PubMed ID: 19242000
[TBL] [Abstract][Full Text] [Related]
43. Antimicrobial formulary management: meeting the challenge in a health maintenance organization.
Carlson JA
Pharmacotherapy; 1991; 11(1 ( Pt 2)):32S-35S. PubMed ID: 2011571
[TBL] [Abstract][Full Text] [Related]
44. PHIRST Trial - pharmacist consults: prioritization of HIV-patients with a referral screening tool.
Awad C; Canneva A; Chiasson CO; Galarneau A; Schnitzer ME; Sheehan NL; Wong AY
AIDS Care; 2017 Nov; 29(11):1463-1472. PubMed ID: 28614952
[TBL] [Abstract][Full Text] [Related]
45. Organization and operation of P & T Committees in the state of Florida: a survey.
Hatton RC; Doering PL
Hosp Formul; 1990 Sep; 25(9):983-6, 988-9. PubMed ID: 10106259
[TBL] [Abstract][Full Text] [Related]
46. Implementation of an outpatient prescription drug formulary in a managed-care system.
Black J; Griffin T; Beisel NW; Bartels MD
Am J Hosp Pharm; 1988 Mar; 45(3):561-5. PubMed ID: 3130754
[TBL] [Abstract][Full Text] [Related]
47. Expert systems. Assisting formulary decision making in the ambulatory setting.
Nash D; Windt PE; Peterson AM
Pharmacoeconomics; 1994 Nov; 6(5):478-9. PubMed ID: 10155275
[TBL] [Abstract][Full Text] [Related]
48. Application of pharmacoeconomics to formulary decision making in managed care organizations.
Suh DC; Okpara IR; Agnese WB; Toscani M
Am J Manag Care; 2002 Feb; 8(2):161-9. PubMed ID: 11858228
[TBL] [Abstract][Full Text] [Related]
49. P & T Committee perspectives: maintaining a successful formulary system in a private community hospital.
Benner EJ; Mykita L; Brown K
Hosp Formul; 1990 Apr; 25(4):423-6, 428, 430. PubMed ID: 10104233
[TBL] [Abstract][Full Text] [Related]
50. Institutional formularies: the relevance of pharmacoeconomic analysis to formulary decisions.
Lipsy RJ
Pharmacoeconomics; 1992 Apr; 1(4):265-81. PubMed ID: 10147017
[TBL] [Abstract][Full Text] [Related]
51. Physicians' behavior and their interactions with drug companies. A controlled study of physicians who requested additions to a hospital drug formulary.
Chren MM; Landefeld CS
JAMA; 1994 Mar; 271(9):684-9. PubMed ID: 8309031
[TBL] [Abstract][Full Text] [Related]
52. Total formulary review--the easy way.
Chase K; Meyer JD; Kelly WN
Hosp Pharm; 1984 Mar; 19(3):159-62. PubMed ID: 10265845
[TBL] [Abstract][Full Text] [Related]
53. Towards a Transparent, Credible, Evidence-Based Decision-Making Process of New Drug Listing on the Hong Kong Hospital Authority Drug Formulary: Challenges and Suggestions.
Wong CKH; Wu O; Cheung BMY
Appl Health Econ Health Policy; 2018 Feb; 16(1):5-14. PubMed ID: 28702874
[TBL] [Abstract][Full Text] [Related]
54. Multi-tier drugs assessment in a decentralised health care system. The Italian case-study.
Jommi C; Costa E; Michelon A; Pisacane M; Scroccaro G
Health Policy; 2013 Oct; 112(3):241-7. PubMed ID: 23850166
[TBL] [Abstract][Full Text] [Related]
55. A P&T Committee's Transition to a Complete Electronic Meeting System-A Multisite Institution Experience.
Al-Jedai AH; Algain RA; Alghamidi SA; Al-Jazairi AS; Amin R; Bin Hussain IZ
P T; 2017 Oct; 42(10):641-651. PubMed ID: 29018301
[TBL] [Abstract][Full Text] [Related]
56. Implementation of hyperlinks to medication management policies and guidelines in the electronic health record.
Dwenger AT; Fox ER; Macdonald EA; Edvalson BJ
Am J Health Syst Pharm; 2019 Sep; 76(Supplement_3):S69-S73. PubMed ID: 31352489
[TBL] [Abstract][Full Text] [Related]
57. Implementation of a formulary management process.
Karel LI; Delisle DR; Anagnostis EA; Wordell CJ
Am J Health Syst Pharm; 2017 Aug; 74(16):1245-1252. PubMed ID: 28790076
[TBL] [Abstract][Full Text] [Related]
58. Effective decision-making in a changing healthcare environment: a P & T Committee interview.
Zoloth A; Yon JL; Woolf R
Hosp Formul; 1989 Feb; 24(2):85-7, 90, 93 passim. PubMed ID: 10291815
[TBL] [Abstract][Full Text] [Related]
59. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
[TBL] [Abstract][Full Text] [Related]
60. Operation, formulary decision-making activities of a P & T Committee in a managed care setting.
Adams J; Richardson J
Hosp Formul; 1991 Apr; 26(4):291-4, 300-1. PubMed ID: 10109798
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
